Cerebral Folate Deficiency and Autism Spectrum Disorder
Cerebral folate deficiency (CFD) is recognized as a metabolic condition associated with autism spectrum disorder (ASD) and represents an important treatable cause of ASD symptoms, particularly in children with neurological deficits. 1
Definition and Mechanism
- CFD is characterized by reduced folate transport to the central nervous system despite normal serum folate levels, resulting in low cerebrospinal fluid (CSF) 5-methyltetrahydrofolate (5MTHF) concentrations 2
- The primary mechanism involves folate receptor alpha autoantibodies (FRAs) that block folate binding sites on choroid epithelial cells, preventing adequate folate transport across the blood-brain barrier 2, 3
Prevalence in ASD
- FRAs have been identified in 58-76% of children with ASD, making it a significant metabolic abnormality in this population 4
- In one study, 75.3% of children with ASD tested positive for FRAs, suggesting a high prevalence of this metabolic abnormality 3
- CFD is listed among recently described metabolic conditions associated with an ASD phenotype in clinical genetics guidelines 1
Clinical Presentation and Diagnosis
- CFD should be suspected in children with ASD who present with:
- Diagnosis involves:
Treatment Approach
- Oral folinic acid (leucovorin calcium) supplementation is the primary treatment for CFD in ASD 2, 4
- Folinic acid can bypass the folate receptor alpha blockage by using an alternate pathway (the reduced folate carrier) 4
- Recommended dosage is 2 mg/kg/day (maximum 50 mg/day) of folinic acid 5
- Treatment duration of at least 12 months may be needed to see significant clinical improvement 2
Treatment Efficacy
- Recent randomized controlled trial (2024) demonstrated that oral folinic acid supplementation significantly improved ASD symptoms compared to placebo 5
- The improvement in Childhood Autism Rating Scale (CARS) scores was significantly higher in the folinic acid group (3.6 ± 0.8) compared to placebo (2.4 ± 0.7) 5
- Children with high titers of folate receptor autoantibodies showed more pronounced benefits from folinic acid treatment 5
- Previous studies have shown improvements in:
Metabolic Pathways and Mechanisms
- CFD may interfere with several metabolic pathways in ASD:
- These metabolic disturbances may contribute to the neurological and behavioral symptoms seen in ASD 6
Clinical Considerations and Pitfalls
- CFD is considered a "low incidence yet high impact" metabolic disorder in ASD 1
- The American College of Medical Genetics does not recommend routine metabolic testing in all ASD cases but emphasizes maintaining a high index of suspicion for metabolic disorders like CFD 1
- Early detection of FRAs may be crucial for prevention and therapeutic intervention 2
- Treatment with folinic acid appears safe with low incidence of adverse effects 5, 3
- Failure to consider CFD in ASD evaluation may miss an important treatable cause of symptoms, especially in children with neurological abnormalities 2